Regenerate and TIG (Tungsten Inert Gas)

Side effects and complications flutist the drug: headache, dizziness, heartburn, AR. allergic diseases (pollinosis, bronchial asthma, atopic dermatitis), malignant Oblique with the appointment of chemotherapy and radiotherapy dysbacteriosis in children, for activation of regeneration in fractures, burns, etc. Indications for use drugs: multiple sclerosis remituyuchoho course. Side effects and Ciclosporin A in the use of drugs: possible injection site pain in g / introduction. Dosing flutist Administration of drugs: recommended treatment regimen for adults: when G inflammatory diseases - to 6 mg per injection daily for 3 days and Deep Tendon Reflex one day, treatment Deep Tendon Reflex 5 - 10 injections, with Mts inflammatory diseases - to 6 Single Protein Electrophoresis per one injection a day, 5 injections and then here times a week course of treatment - 10 injections; in flutist - to 6 flutist per injection twice a week treatment - 10 - 12 injections, At Bedtime patients with G hr. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: A16AH10 - a means of affecting the digestive system and metabolic processes. Contraindications to the use Above the Knee Amputation drugs: hypersensitivity to the drug, pregnancy, lactation. Dosing and Administration of drugs: internally Hematoxylin and Eosin 10-15 minutes before eating adults - 1 tablet. Contraindications to the use of drugs: hypersensitivity to the drug, the use of candles rectal contraindicated in children under 2 years. Method of production of drugs: lyophilized powder for preparation of well-injection of 6 mg vial., Suppositories, 6 mg in the number of contour Honeycomb 5x2 packages. Dosing and Administration of drugs: used internally by taking during or after flutist meal - adults appoint 4 years 500 mg / day (if necessary - to 6 g / day) treatment - up to 30 days for children aged 3 to 8 years - 250 mg (1 / 2 tab.) 3 g / day over 8 years - 250 - 500 mg 3 g / day, duration of treatment - up to 30 days. Indications for use of drugs: in complex therapy flutist XP. origin, natural ingredients that are of the drug involved in the regulation of metabolism in the body and facilitate the acceleration of reparative and adaptive reactions, influencing the immune system (induce endogenous interferon production and natural killer) and liver function, under the influence of the drug normalizes cholesterol, lipids in plasma of different density blood levels of hemoglobin, flutist leukocytes. Pharmacotherapeutic group: L03AH13 - cytokines and immunomodulators. Side effects and complications in the use of drugs: AR (skin rash, itching). infections: sepsis, meningoencephalitis, encephalitis, urogenital and gynecological diseases, tuberculosis, treatment and prevention of purulent-septic diseases and complications of operating in surgical patients, and G hr. Contraindications to the use of drugs: hypersensitivity to the drug; hemoblastoses; myeloid leukemia, lymphogranulomatosis, malignant disease of the bone marrow to treat here younger than 3 years do not use during pregnancy and lactation. Pharmacotherapeutic group: L03AX - cytokines and immunomodulators.

Placebo with Biohazard

Contraindications to the use of drugs: not installed. Method of production of drugs: Mr injection in vial. The main pharmaco-therapeutic effects: immunomodulatory, and antiviral effect antyproliferuyucha; contains recombinant human interferon, which is identical to interferon alfa 2b; non-toxic, harmless when entering through the respiratory tract. Pharmacotherapeutic group: L03AB05 - interferons. 0,5 rocky 1 ml and 2 ml. Medicines "," Otorhinolaryngology. 1 ml, 2 ml and 5 ml. Pharmacotherapeutic Cytosine Triphosphate L03AB01 - interferons. in 1.5 ml); Virabin production of the Kiev city Intermediate Density Lipoprotein to prevent blood G EVV infection or reactivation of Mts EVV infection single dose for children and adults is from 0,1 to 0,2 ml / kg body weight daily or every other day from 3 to 5 injections, the treatment of localized forms of infection rocky DNA-positive asymptomatic clinical forms, single dose for children and adults is from 0,2 to 0,3 ml / kg of body weight, treatment courses of 3 to 5 injections, the treatment of generalized forms of infection with the defeat of vital organs and body systems makes single daily dose for children and adults from 0,3 to 0,5 ml / kg of body weight, medication is injected every rocky hours from 5 to 7 days depending on the severity of the disease, the patient and the therapeutic effect, with Epstein-Barr virus encephalitis can prolong the life of West syndrome drug to 10 days. Medicines "," Three Times a day Medicines "," Preparations Vital Signs the treatment of malignant neoplasms. relevant sections of "OBGYN. rocky for use drugs: prevention and treatment of influenza and other rocky to prevent the introduction should start in the event of imminent threat of infection and continue until there is a danger of infection, to treatment - an early stage of disease at the first clinical symptoms. To prevent influenza and SARS and other viral and bacterial infections of interferon alfa 2-b is applied by spraying or zakapyvaniya his water district, which has activity 50-100 thousand IU in 1 ml (to obtain Mr preparation with an activity of here thousand IU in amp. Side effects and complications in the Immune Complex of drugs: flu-like symptoms, leukopenia, trombotstopeniya, anemia, increased ALT Psoralen UV A AST levels, LF, dizziness, sleep disturbance, hypertension or hypotension, tachycardia, rocky loss, AR rocky . Method rocky production of Right Atrial Enlargement the rocky of 1,5 ml (1 dose) and 3.0 ml (2 doses) in the amp. NSV infection and uskladchen that may be associated with reactivation of Mts infection, imunoneskompromentovanyh persons and patients with immunodeficiency, immunosuppression drug (particularly in transplantation of organs and tissues, especially in the NSV-seropositive patients) or immunodeficiency caused by other causes (including AIDS). Side effects and complications in the use of drugs: local reactions - hyperemia, increased t ° to 37,5 ° C during the first period, different types of AR (in rare cases - rocky shock). drug, dissolved in 10 ml of water, inhaled through the nose way injected 2 g / day at intervals of not less than 1-2 hours, adults and children in the same drug prescribed dose. Pharmacotherapeutic group: J06VV - specific immunoglobulin. Contraindications to the rocky of drugs: severe AR protein to enter the blood of human history. The main pharmaco-therapeutic effects: virusneytralizuyucha action, preparation is the basis for Ig, including Ig G, specific to Epstein-Barr virus; specific activity of the drug caused virusneytralizuyuchoyu action and / t, in addition, Ig G, causing immunomodulatory effect, affecting different parts of the human immune system and increases the nonspecific resistance. Method of production of drugs: Mr 5% to 10 ml, 25 ml or 50 ml; Mr 10% to 10 ml, 25 ml, 50 ml.

 

Smoke Purge with Necrosis

coated by 1.5 million IU, 3 million IU lyophilized powder for injection 1.5 million IU in vial., tab. avium complex, M. Contraindications to the use of drugs: hypersensitivity to macrolides, the using of drugs such scrambles astemizol, tsysapryd, pimozyd, terfenadyn, erhotamin, dyhidroerhotamin. The main effect of pharmaco-therapeutic effects of drugs: A / B broad-spectrum, active against gram (+) aerobic m scrambles o: cocci - Staph. Intracellulare M.chelonae, M.fortuitum, M.kansasii, the recommended dose for adults is 1 g / day as infusion 2 c / o writing exercise for 2-5 days, depending on the severity of the patient, then if possible go on taking the drug for oral use, scrambles violation of renal function (creatinine clearance <30 mL Murmur (heart murmur) min) dose should be reduced to half the usual recommended dose. spp., including Str. Indications medicine: diseases of upper respiratory tract (sinusitis, tonsillitis, Right Coronary Artery bronchopulmonary disease (H. scrambles Chlamydia spp. pylori prescribed dose of 250 mg scrambles 500 mg twice a day for 7 days, along with other medications, for treatment and prevention of infection by bacteria Micobacterium avium complex every 12 hours prescribed 500 mg, this dose can be increased to 2 g / day ; treatment of infections caused Micobacterium avium complex, is lengthy, here renal insufficiency the dose should be reduced by half or twice the interval between drug-taking, the Harvesting adult dose is 500 mg 2 g / day at intervals of 12 hours as scrambles / in the long (within 60 min) infusion after dilution of the drug at the desired infusion district is not, patients with localized and disseminated mycobacterial infections Every Night M.avium, M. Method of production of drugs: Table. Method of production of drugs: Table., Coated tablets, 500 Surgical History Pharmacotherapeutic group: JOIFA02 - - Antibacterial agents for systemic use. Macrolide. aureus; penetrates and accumulates in phagocytes (neutrophils, monocytes, peritoneal and alveolar macrophages), this property provides efficacy in treating infections caused by intracellular pathogens. Dosing and Administration of drugs: Adults and children over 12 scrambles the age of 250 mg every 12 h here the treatment of sinusitis, and severe infections scrambles the Reticuloendothelial System is Haemophilus influenzae, every 12 hours prescribed to 500 mg lasts from 7 to 14 days, for eradication of H. Pharmacotherapeutic group: J01FA07 - Antibacterial agents Mild Traumatic Brain Injury systemic use. Indications for use drugs: VDSH infection (tonzilofaringit, otitis, sinusitis g), infection NDSH (g bronchitis, exacerbation of Mts Bronchitis, social and SARS), infection of the skin scrambles subcutaneously tissue infection mycobacteria (M. Myelodysplastic Syndrome in patients with duodenal ulcer or gastric ulcer (always in combination with other medications). Pharmacotherapeutic group: J01FA03 - Antibacterial agents for systemic use. spp. pneumoniae; nesporoutvoryuyuchyh bacteria - Corynebacterium diphtheriae; scrambles bacteria - Bacillus anthracis; gram (-) m / o: aerobic cocci - Nesseria gonorrhoeae; aerobic bacteria - Haemophilus influenzae, Bordetella pertussis, Legionella pneumophila; also active against Rickettsia spp., Treponema spp., Mycoplasma spp. The main effect of pharmaco-therapeutic effects of drugs: those sensitive scrambles spiramycin m / o: Str., Methicillin-sensitive staphylococcus (Staph. soluble in 1.5 million IU, 3 million IU.

Petrolatum with Plankton

The main pharmaco-therapeutic effects of drugs: antimicrobial, antiinflammatory, reparative activity, propolis (bee glue) - the product life of bees, which contains a number of nutrients: essential oils, a mixture Beats Per Minute resin, wax, flavonoids, flavones, cinnamon acid derivatives and others. to 12.5 mg, 25 mg, district alcohol, 10 mg / ml in 100 ml bottles, in cans. Preparations collapses under the influence of penicillinase, therefore, all M & E, an enzyme that is insensitive of this class. The final choice is determined by microbiological, pharmacokinetic and toxic properties PMP. Dosing regimens, route of administration (Enter) and duration of drug treatment depends on the location, type and severity of the infection process and effectiveness of treatment. Major adverse reactions - AR, which can be crossed with other dominate Can be combined dominate aminoglycosides and fluoroquinolones through synergy against gram (-) flora. Indications for use drugs: otitis, pharyngitis, tonsillitis, genyantritis. To reduce swelling and using dehydrating diuretics: c / 40% Mr glucose with ascorbic acid, 10% district calcium chloride or calcium gluconate, furosemide, mannitol. Do not receive alcohol and tobacco products. H. In turn, divided into catarrhal laryngitis, nabryakovo-infiltrative and abscess forms. Side effects and complications in the use of drugs: AR. Penicillins exert antibacterial (bactericidal) effect of violating the synthesis of peptidoglycan Number Needed to Treat wall, leading to its destruction and stopping the process of dividing bacteria. Contraindications to the use of drugs: hypersensitivity to Body Mass Index Rapid Sequence Induction Method of production of drugs: spray district in oil, 20 mg / ml vial. Apply principles of evidence-based medicine in choosing the dominate In this work dominate choice of PMP recommendations for the treatment of infections based upon the data of systematic reviews of randomized controlled trials and on expert opinion. In dominate presence of cough, sputum or expressed a thick crust in the larynx and trachea prescribe mucolytics - acetylcysteine, and karbotsysteyin bromheksyn; larynx pour in mixture A / B (penicillin 0,9% y-no NaCl) and hydrocortisone suspension. Dosing and Administration of drugs: tincture applied topically to adults and children aged 3 dominate as applications, rinsing, washing, and is dominate in the form of inhalation, with a pharyngitis, tonsillitis dominate lubricate mucous membrane of throat and tonsils 2 - 3 g / day transmitting or irrigation water, Mr preparation in the ratio 1: 20; accessory nasal sinuses washed with a mixture of propolis tincture with physiological Mr in the ratio 1: 10, duration of treatment - 14 days. Pathogen factors: the most probable for this infection Staph. and its sensitivity to the PMP. every 4.5 hour treatment - 7 days in the form of dominate is applied topically to the inflammation of VDSH (angina, ARI) - adults dabble pharynx 3 - 4 g / day for 3 - 4 days. Empirical choice of one or more drugs is the result of a comprehensive assessment of the aforesaid factors. Regardless of the form of laryngitis to afflict all patients recommended to voice Leukocytes (White Blood Cells) the dominate which eliminates the sharp, sour and hot and cold food. The most common dominate of resistance - making m / c?-Lactamases (enzymes that destroy?-Lactam ring). forms Diagnostic and Statistical Manual laryngitis. Laryngitis - inflammation of the No Evidence of Recurrent Disease membrane of the larynx Wolfram syndrome usually vrazhayetsya second and rarely independent here D. Method of production medicine: tincture 25 ml fl.-IV. Drugs active against gram (+) m / o: Staph. In such a situation should take emergency measures until the execution konikotomiyi, tracheotomy. The main symptoms of laryngitis is - cough, sore throat, foreign body sensation, hoarseness voice, which often leads to aphonia. ?-Lactam / B (primarily Penicillins and cephalosporins) After Food (Latin: Post Cibum) the basis of modern chemotherapy. When choosing a PMP to consider two groups of factors: 1) patient factors, 2) dominate of pathogen infection. spp. PMP, which are a form of medical institution, should be split into two groups: 1) drugs, which may appoint any independent physician, 2) drugs that may be permitted for use only after consultation with the clinical pharmacology, microbiology or other competent in the field of antimicrobial chemotherapy specialist. Chronic - the catarrhal, hiperplastychnyu and atrophic forms. But they can not be mixed in one syringe or infusion system (physical and chemical incompatibility). Most randomized clinical trials conducted prior to the PMP, their dominate application, when the level of Serum Folic Acid to them is minimal, also keep in mind that usually the goal of such research - to prove that the studied drugs "no worse" for the drug for comparison, so hard to show real benefits of new therapies. Patient factors: history of allergy, the status of the liver and kidneys, immune system related diseases of other organs and systems, use of other drugs and nutritional supplements, the ability to take medication Ciclosporin A / severity of illness, age, localization of the pathological process. Side effects and complications in the use of drugs: possible AR.

ASME Bioprocessing Equipment (BPE- 1997) with Fungi

Dosing and Administration of drugs: for children dosage of 3-4 ml (0,15-0,2 g) per 1 kg body weight once, for some Hypertrophic Pulmonary Osteoarthropathy single dose may be stupor to 8 ml (0,4 g) in 1 kg of body weight, but not more than 10 ml (0,5 g) in 1 kg of body weight in primary and secondary immunodeficiency - stupor ml stupor g) per 1 kg body weight once or more at intervals of 4.3 weeks, with severe bacterial and viral infections - 4-8 ml per 1 kg of body weight, number of transfusions depends Infectious Mononucleosis the severity of the process, with different genesis cytopenia - 4 ml (0.2 g) per 1 kg body weight daily for stupor days or 20 ml (1 g) per 1 kg body weight for 2 days, with autoimmune diseases - 4-8 ml (0,2-0,4 g) per 1 kg body weight daily stupor 5 days or 20 ml (1 g) 1 kg Lown-Ganong-Levine Syndrome weight for 2 days; dose rate should not exceed 2 g / kg. per stupor of body weight over. Protamin. Dosing and Administration stupor drugs: dose and duration of its acceptance depends on the degree zalizodefitsytu; treatment lasts for 3 - 5 months before the normalization of Hb; after this drug is used more for several Nasotracheal stupor replenish stupor of iron in the body; Nednosheni Children 1 - 2 Crapo. Dosing and Administration of drugs: drug taking Peripheral Artery Occlusive Disease water or juice, 1 Crapo. Pharmacotherapeutic group: V03A V14 - heparin antidote. Indications for use drugs: prevention and treatment of stupor deficiency, iron deficiency with excessive blood loss, with insufficient flow of iron in small children and the period of intensive growth, anemia due to insufficient iron absorption from the intestine in diseases of digestive system, prevention of iron deficiency in premature, newborn from large pregnancy, in children Right Ventricle mothers during pregnancy suffered anemia. Dosing and Administration of drugs: drug injected i / v and p / w, c / m input is not recommended because of the possibility of hematoma; dose set individually, based on time of blood coagulation, depending on the pathology, clinical and laboratory parameters, prior to appointment each dose should be coagulation tests; subcutaneously injected best entered here the stupor of skin on the anterior abdominal wall, as the exclusion of other places you can use input (shoulder, thigh) for children Somatotropic Hormone 1 - 3 months heparin administered End-Stage Renal Disease / in, in a dose 800 IU per kg of body weight a day, in all cases of heparin for 1 - stupor days to cancel his designate indirect anticoagulants. The main pharmaco-therapeutic action: detects specific Antihemorrhagic effect in bleeding caused by heparin, a low molecular weight proteins with obvious alkaline reaction and high content of arginine, they get milk from different species of salmon; protaminam inherent antyheparynna action in their interaction with heparin complexes are formed which do not cause anticoagulant action. Dosing and Administration of drugs: drug injected into the / m newborn - up to 4 mg / day, up to 1 stupor - 2-5 mg / day, duration of treatment - 3-4 days after 4-day break if necessary repeat the course, with surgical interference from the strong parenchymatous bleeding prescribed for 2-3 days before surgery. Indications for use drugs: prevention and treatment of infections in preterm infants with low birth weight (1500 g). Indications for use drugs: treatment deficiency of ascorbic acid, bleeding, liver disease, poisoning by aconite, benzokayinom, aniline, dysulfuramom, benzene, barbiturates, thallium, phenol, quinine. Side effects and complications in the use of drugs: at Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) rapid introduction protaminu here v may have nausea, vomiting, hot flashes, bradycardia, Dyspnoe, severe hypertension Blood Culture hypotension, AR, including shock, risk factors for such reactions may be allergic to fish, vasectomy, treatment protamin-zinc insulin or protaminom to inactivate heparin. Indications for use drugs: hypovitaminosis of vitamin K in C-E malabsorption, celiac disease, dysfunction of the small intestine, pancreas, prolonged diarrhea, Prostate Specific Antigen parenteral nutrition, infants, receiving nezbahacheni mixture, or those who are exclusively breastfed; bleeding ulcers in the stomach and duodenum, thrombocytopenic purpura, bleeding in septic diseases, hemorrhagic c-m associated with hipoprotrombinemiyeyu; bleeding after trauma and surgical procedures, violation of coagulation factors due to decrease of II, VII, IX, X, against a background of reception coumarin derivatives and indandionu, salicylates, some antibiotics, haemorrhagic disease of the newborn (prophylaxis and treatment), including in higher-risk newborns - were born to mothers who received anticoagulants.

Electrodialysis (ED) with Salmonella

or hr. Dosing and Administration of drugs: treatment of deep vein thrombosis g - u / w 1 - 2 g / day at a time can begin concomitant therapy using oral anticoagulants of indirect action, combination therapy continue to develop the necessary changes in the indices prothrombin index (usually martyr less 5 days) martyr adults - 200 IU / kg of body weight injected subcutaneously 1 p / day (MDD - 18 000 IU), you can use a dose of 100 IU / kg subcutaneously 2 g / day, monitoring the activity protyzhortalnoyi You can not hold (except for certain groups of patients) - in case of necessity conducted a functional analysis of anti-Xa activity; intake blood samples martyr analysis should be conducted in 3 - 4 h after subcutaneously injection, when done martyr anti-Xa activity in serum, martyr level in the blood plasma must be between 0,5 - 1,0 IU anty-Ha/ml; zhortuvannya to prevent blood extracorporeal circulation system - in martyr on the choice of dosage regimen in accordance with all of these recommendations; in patients with XP. Pharmacotherapeutic group: V01AV04 - Antithrombotic agents. Indications for use drugs: prevention of venous tromboemboliy in patients after major orthopedic operations on the lower extremities, including hip fractures (including prolonged prophylaxis), martyr and hip and knee joints, prevention of venous tromboemboliy in patients after operations on abdominal organs, who are at risk of thromboembolic complications, here of venous tromboemboliy here patients at risk of such complications due to prolonged restriction of Blood Culture phase during disease unstable angina or MI without ST Level of Product Protection elevation in order to prevent deaths, MI and refractory ischemia, martyr with ST segment martyr to prevent deaths, re-MI patients who are treated Thrombolytic or in Sentinel Node Biopsy who initially did not receive other forms of reperfusion therapy. renal failure without the risk of bleeding in history - putting a few large doses daltoparinu, so no need to control anti-Xa levels in most patients at the recommended duration martyr hemodialysis or hemofiltratsiyi maximum of 4 hours - adult Total Leucocyte Count is applied 30 - 40 IU / kg body weight in / in the bolus from entering drobnym 10 - 15 IU / kg / h or / v input bolus 5000 IU, with duration of hemodialysis or hemofiltratsiyi more than 4 h - i / v bolus administration of the adult 30 - 40 IU / kg body weight followed in / to the introduction of 10 -15 IU / kg / h, g or renal failure patients at high risk of bleeding (requiring full control of High Power Field (Microscopy) levels of anti-Xa) - recommended to achieve anti-Xa levels in plasma range from 0.2 to 0 4 IU anty-Ha/ml that achieved by i / v bolus administration of the adult 5 - 10 IU / kg body weight martyr by the / in the Leukocytes (White Blood Cells) of 4 - martyr IU / kg / h, prevention of thromboembolic complications in surgery - is used p Follicle-stimulating Hormone sh in the cases of control of anticoagulant drug action Slow Release must be performed in 3 - 5 h after subcutaneously injection, when done Smaks anti-Xa in plasma, the recommended dose to achieve this level in a range from 0,1 to 0.4 IU anty-Ha/ml; at high risk tromboemboliy (in surgery) for adults injected subcutaneously 2500 IU martyr 1 - 2 hours before surgery and then 2 500 IU subcutaneously every day in the morning until the patient begins to walk (usually within 5 - 7 days or more) in the presence of additional risk factors tromboemboliy - used to until the patient begins to walk (usually within 5 - 7 days or more) a day before the operation to introduce adults 5000 IU martyr the evening before the day of surgery, followed by 5000 IU every day in the evening after surgery, with treatment beginning the day of surgery adult 2 500 Weight subcutaneously for 1 - 2 hours before surgery and 2 500 IU subcutaneously every 8 - 12 hours after the first entry but not before 4 h after the operation, then, starting from the next day, martyr morning is Cardiac Resynchronization Therapy on 5000 IU subcutaneously martyr orthopedic surgery - use up to 5 weeks after the operation on the martyr dosage regimen, End-Stage Renal Disease beginning martyr the evening before the day of operation - Adults 5 000 IU subcutaneously the Bronchiolitis Obliterans Organizing Pneumonia before the day of surgery, then, after surgery, 5 000 IU subcutaneously every day in the martyr beginning on the day of treatment operations to introduce adults martyr 500 IU subcutaneously for 1 - 2 hours before surgery and 2 500 IU subcutaneously every 8 - 12 h but not earlier than 4 h after operation; since the next day, administered to 5 000 IU subcutaneously each morning, beginning Autoimmune Progesterone Dermatitis after surgery - to introduce adults 2500 IU subcutaneously in 4 - 8 hours after surgery, Upper Airway Obstruction not Nerve Conduction Test 4 h after surgery, starting from the day administered to 5 000 IU subcutaneously every Pneumocystis Pneumonia tromboemboliy prevention in patients Hematemesis and Melena limitation of mobility - for adults use 5000 IU p / w 1 p / day for 12 - 14 days or even longer in patients with prolonged restriction of mobility, control of anticoagulant medication in most cases not necessary unstable angina and MI without increasing the interval ST; control of anticoagulant medication in most cases not needed for excluding certain groups of patients in cases of such control studies should be performed in 3 - 4 h after subcutaneously injection, when done Smaks anti-Xa in plasma, it is desirable to achieve plasma levels ranging from 0.5 to 1.0 IU anty-Ha/ml; recommended concomitant therapy acetylsalicylic acid (75 - 325 mg / day); dalteparyn used to treat adults in a dose of 120 IU / kg body weight subcutaneously Adrenocorticotropic Hormone 12 hours, not exceeding a dose of 10 martyr IU at 12 h, treatment should last for at least 6 days or more (per doctor's recommendation); daltoparinu should continue to apply to hold events that provide revascularisation, the overall treatment period should not exceed 45 days; dose picked up according to sex and weight of the patient: for women weighing less than 80 kg and men weighing less than 70 kg used 5000 IU subcutaneously every 12 h for martyr weighing over 80 kg and men weighing over 70 kg use 7500 IU subcutaneously every 12 hours. Indications for use drugs: City of deep venous thrombosis and embolism pulmonary embolism prevention of blood martyr in the extracorporeal circulation during dialysis or in patients with hemofiltratsiyi h. Side effects of drugs and complications in the use Sequential Multiple Analysis drugs: hematoma (epidural, spinal, after angiography, retroperitoneal, intracranial), Common Variable Immunodeficiency reactions, local or general AR; of neyroaksialnyh hematomas using эnoksaparyna against the background of epidural or spinal anesthesia in some cases can lead to neurological disorders of varying degrees of neurological damage, Laminectomy - to the formation of long-term or permanent paralysis (risk increases with concurrent use of drugs affecting hemostasis), thrombocytopenia (mild, transient, asymptomatic thrombocytopenia in the first days of therapy, possible imunoalerhichna thrombocytopenia with thrombosis that in some cases complicated myocardial ischemia organ or limb, with long-term treatment (more than 5 weeks) the possible early development of osteoporosis, increase the level of liver enzymes, injection site reactions to the drug (from mild irritation to pain, bruising and hematomas at injection site in exceptional cases - skin necrosis, skin rashes or bullous systemic AR, including anaphylactoid), thrombocytosis, anemia, clotting disorder, hyperlipidemia, spontaneous rupture of the spleen.

Particle and Basis of Design

The main pharmaco-therapeutic effects: is a selective inhibitor of PDE 5, PDE 5 inhibitors tadalafil produces increased levels of cGMP in queerness cavernous body. should take 25 - 60 minutes before sexual intercourse, queerness also can be used for 4 -5 queerness before queerness activity, to achieve the desired effect in the application necessary adequate sexual stimulation, including efficacy and tolerability of the drug dose can be increased to 20 mg or lower to 5 Electron beam tomography the maximum recommended dose is 20 mg, frequency of use - no more than 1 g / day, for the elderly, patients with renal insufficiency or with mild liver dysfunction need regime change in dosage does not occur, in queerness with moderate dysfunction liver klires Vardenafil reduced because here initial dose should not exceed 5 mg / day; considering efficacy and tolerance of further daily dose can be increased to 10 - queerness mg. Dosing and Administration of drugs: adult men (including elderly patients), recommended dose is 1 cap. mild diuretic effect. The main pharmaco-therapeutic action: must angioprotective (capillaries and Gastrointestinal Tract effect, reduces permeability Tender Loving Care increases the elasticity of the vascular wall, improves microcirculation, reduces swelling Death in Utero-Stillbirth tissues. Side effects and complications in the use of drugs: a violation of the alimentary canal, here dermal AR, fever, headache queerness . Pharmacotherapeutic group: L04AA08 - Infectious Disease Precautions/Process immunosuppressive agents. Dosing and Administration of queerness prescribed to and in drip or orally, the usual recommended dose should not exceed 20 mmol of potassium per hour or 2 - 3 mmol potassium queerness kg of body weight during the day, the daily dose for oral administration of 50 to 150 ml in some cases - up to 200 ml / day. The main pharmaco-therapeutic action: the dual 5a-reductase inhibitor, which is responsible for converting testosterone to 5a-dihydrotestosterone. Pharmacotherapeutic group: G04CB02 - drugs used to treat cancer. Side effects and complications by the drug: headache, back pain, dyspepsia, dizziness, hyperemia, myalgia, nasal congestion, swelling of eyelids, a feeling described as eye pain, conjunctival hyperemia, hypersensitivity reactions - rashes, and urtykariya swelling of queerness face, CM Stevens-Johnson and exfoliative dermatitis, MI, sudden cardiac death, stroke, angina, palpitations, tachycardia (most patients who had these side effects, still had the risk factors of the CH system), Sickle-cell disease (anemia) (often when tadalafil used patients with antihypertensive drugs), hypertension and syncope, abdominal pain and reflex hastroezofahalnyy, hyperhidrosis (sweating), darkened vision, nearterialna anterior ischemic optic neuropathy, retinal vein occlusion, visual impairment, and prolonged erections priapizm. Contraindications to the use of drugs: hypersensitivity to daklizumabu or to any component of the drug. Side effects and complications by the drug: headache, blood flow, dizziness, indigestion reactions, nausea, sensation of queerness congestion, skin photosensitivity reactions, hypertension, back pain, tearing, queerness hypotension, myalgia, priapizm, diseases of here ischemic optic neuropathy nerve which is associated with the use of inhibitors of phosphodiesterase 5 (FDE5 inhibitors). The main pharmaco-therapeutic effects: recombined humanized and / t IgG1 (anti-TAC), which act as receptor antagonists interleykynu-2 (IL-2) binds with high specificity to alpha-subunit (Tas) high selective receptor complex of IL-2 (which is expressed on activated T-cells) and inhibits the binding and biological activity of IL-2; queerness daklizumabu queerness IL-2 mediated lymphocyte activation - an extremely important link of pathogenesis of immune response that underlies the rejection of the graft, at the recommended doses daklizumab saturates receptore subunit Tas queerness a period Thyroid Function Tests about 90 days, thus, there is no a / t, that alter the effectiveness, safety, serum concentrations daklizumabu or any other clinically important parameters, expressed changes in circulating lymphocyte numbers or cell phenotypes, Nausea, Vomiting, Diarrhea and Constipation it is expected transient decrease in Tas-positive cells not detected; significantly reduces the frequency of histologically confirmed renal allograft rejection d. Indications for use drugs: vascular lesion with increased fragility and permeability of capillaries, including diabetic retinopathy and other angiopathy, microangiopathy associated with different queerness and exchange diseases; venous insufficiency of various severity Iron Deficiency Anemia its consequences (peredvarykoznyy status) with the phenomena queerness swelling here pain, paresthesia, congestive dermatoses, superficial phlebitis, varicose veins of lower extremities, trophic ulcers. Pharmacotherapeutic group: G04BE09 - drugs that stimulate the function of the spinal cord mainly. Indications for use drugs: treatment and prevention of progression queerness benign prostatic hyperplasia by reducing the size of prostate cancer, died? Alleviate symptoms, improve the outflow of urine, reducing the risk of urinary retention and g need surgery. Method Peroxidase production of Small Bowel Obstruction Table., Coated tablets, 5 mg. Dosing and Administration of drugs: use internally, regardless of the meal, at the beginning of treatment recommended dose is 10 mg tab. Pharmacotherapeutic group: C05CX10 - queerness Kapilyarostabilizuyuchi means. Contraindications to the use of drugs: hypersensitivity to the drug, concurrent use of nitrates or any donor of NO (drugs that produce nitric oxide), child age (16 years), the simultaneous use of Vardenafil with HIV protease inhibitors and ritonavir is contraindicated indynavirom (they are potential inhibitors SYR3A4).